2002
DOI: 10.1074/jbc.m201147200
|View full text |Cite|
|
Sign up to set email alerts
|

BRCA1-induced Apoptosis Involves Inactivation of ERK1/2 Activities

Abstract: Breast cancer remains the most common cancer affecting women in the Western world. Although most breast cancers are sporadic, ϳ10% are inheritable and associated with mutations in at least two loci, BRCA1 and BRCA2. The BRCA1 gene is located at position 17q21 of the human genome, and mutations in this gene are associated with an increased risk of development of breast and ovarian cancer (1). The BRCA1 gene encodes a protein of 1864 amino acid residues that is primarily located in the nucleus (2). The BRCA1 gen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
37
0

Year Published

2003
2003
2016
2016

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 48 publications
(38 citation statements)
references
References 36 publications
(43 reference statements)
1
37
0
Order By: Relevance
“…The specific downstream effects of Erk1 and Erk2 activation in the mammary epithelial cells are still not defined. However, a recent report indicates that inhibition of Erk1 and Erk2 activation results in increased apoptosis after BRCA1 expression in MCF-7 breast cancer cells (Yan et al, 2002). This suggests that the increases in Erk1 and Erk2 activation associated with MUC1 overexpression could provide a mechanism for the failure to eliminate cells by apoptosis, resulting in premalignant hyperplasia that contributes to mammary tumors.…”
Section: Discussionmentioning
confidence: 84%
“…The specific downstream effects of Erk1 and Erk2 activation in the mammary epithelial cells are still not defined. However, a recent report indicates that inhibition of Erk1 and Erk2 activation results in increased apoptosis after BRCA1 expression in MCF-7 breast cancer cells (Yan et al, 2002). This suggests that the increases in Erk1 and Erk2 activation associated with MUC1 overexpression could provide a mechanism for the failure to eliminate cells by apoptosis, resulting in premalignant hyperplasia that contributes to mammary tumors.…”
Section: Discussionmentioning
confidence: 84%
“…The increased susceptibility to apoptosis may be due, in part, to BRCA1-induced down-regulation of Bcl-2 and the transcriptional co-factor (p300) (Fan et al, 1998b(Fan et al, , 2001c, up-regulation of a Gadd45/JNK signaling pathway (Harkin et al, 1999), and up-regulation of the FasL/ Fas interaction (Yan et al, 2002). BRCA1-mediated apoptosis is also negatively regulated by activation of the ERK1/2 pathway (Yan et al, 2002). The dual roles of BRCA1 in DNA damage repair and apoptosis may be reconciled by postulating a ''caretaker'' function, in which BRCA1 mediates DNA damage signaling/repair when possible, but pushes cells into apoptosis when the damage is too great to repair.…”
Section: Apoptosismentioning
confidence: 99%
“…Similar to our findings with ZBP-89, overexpression of BRCA1 in MCF-7 breast cancer cells also activates both JNK (proapoptotic) and ERK (antiapoptotic) pathways, and MEK1/2 inhibition enhances BRCA1-induced apoptosis. 53 In fact, recent microarray analysis of MCF-7 cell line have revealed that ZBP-89 increases two-fold with overexpression of BRCA-1, suggesting that ZBP-89 lies downstream of this tumor suppressor gene product. 3 Thus, there may be synergy between BRCA1 and ZBP-89 apoptotic pathways.…”
Section: Ibmentioning
confidence: 99%